Specimens can be used to validate SARS-CoV-2 in vitro diagnostics, develop new drugs and vaccines, and investigate the impact of co-morbidities and social demographics on disease progression
Researchers, ethicists urge policymakers to view immortal cells differently from other biospecimens as new rules go into effect
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.